Long-term results of prednisone treatment for the anemia of myelofibrosis.

Abstract excerpt

This study has retrospectively analyzed the efficacy of single-agent prednisone, usually given after failure of other therapies, in 30 patients with myelofibrosis (MF) and severe anemia. Initial dose was 0.5-1 mg/kg daily, with tapering to the minimum effective dose in responders. Twelve patients (40%) achieved anemia response according to the revised International Working Group for Myelofibrosis Research and...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anemia
• Share to Anti-Inflammatory Agents